Mitochondria as central regulators of neural stem cell fate and cognitive function

M Khacho, R Harris, RS Slack - Nature Reviews Neuroscience, 2019 - nature.com
Emerging evidence now indicates that mitochondria are central regulators of neural stem
cell (NSC) fate decisions and are crucial for both neurodevelopment and adult …

Novel approaches for the treatment of Alzheimer's and Parkinson's disease

M Van Bulck, A Sierra-Magro, J Alarcon-Gil… - International journal of …, 2019 - mdpi.com
Neurodegenerative disorders affect around one billion people worldwide. They can arise
from a combination of genomic, epigenomic, metabolic, and environmental factors. Aging is …

Current and emerging avenues for Alzheimer's disease drug targets

R Loera‐Valencia, A Cedazo‐Minguez… - Journal of internal …, 2019 - Wiley Online Library
Abstract Alzheimer's disease (AD), the most frequent cause of dementia, is escalating as a
global epidemic, and so far, there is neither cure nor treatment to alter its progression. The …

Aging, lifestyle and dementia

D Wahl, SM Solon-Biet, VC Cogger, L Fontana… - Neurobiology of …, 2019 - Elsevier
Aging is the greatest risk factor for most diseases including cancer, cardiovascular disorders,
and neurodegenerative disease. There is emerging evidence that interventions that improve …

[HTML][HTML] Mechanism of metformin regulation in central nervous system: Progression and future perspectives

G Cao, T Gong, Y Du, Y Wang, T Ge, J Liu - Biomedicine & …, 2022 - Elsevier
Metformin as a first-line drug for type 2 diabetes mellitus (T2DM) treatment is widely studied.
Metformin can reduce liver glucose output and improve insulin resistance. Recent evidence …

Metformin vs sulfonylurea use and risk of dementia in US veterans aged≥ 65 years with diabetes

AR Orkaby, K Cho, J Cormack, DR Gagnon, JA Driver - Neurology, 2017 - AAN Enterprises
Objective: To determine whether metformin is associated with a lower incidence of dementia
than sulfonylureas. Methods: This was a retrospective cohort study of US veterans≥ 65 …

Rosmarinic acid and ursolic acid alleviate deficits in cognition, synaptic regulation and adult hippocampal neurogenesis in an Aβ1-42-induced mouse model of …

FJ Mirza, S Amber, D Hassan, T Ahmed, S Zahid - Phytomedicine, 2021 - Elsevier
Background Rosmarinus officinalis, commonly known as rosemary, is a medicinal herb that
presents significant biological properties such as antimicrobial, antioxidant, anti …

Repurposing metformin to treat age-related neurodegenerative disorders and ischemic stroke

S Sharma, S Nozohouri, B Vaidya, T Abbruscato - Life sciences, 2021 - Elsevier
Aging is a risk factor for major central nervous system (CNS) disorders. More specifically,
aging can be inked to neurodegenerative diseases (NDs) because of its deteriorating impact …

Actions of metformin in the brain: a new perspective of metformin treatments in related neurological disorders

N Li, T Zhou, E Fei - International Journal of Molecular Sciences, 2022 - mdpi.com
Metformin is a first-line drug for treating type 2 diabetes mellitus (T2DM) and one of the most
commonly prescribed drugs in the world. Besides its hypoglycemic effects, metformin also …

Examples of inverse comorbidity between cancer and neurodegenerative diseases: a possible role for noncoding RNA

M Salemi, MP Mogavero, G Lanza, LM Mongioì… - Cells, 2022 - mdpi.com
Cancer is one of the most common causes of death; in parallel, the incidence and
prevalence of central nervous system diseases are equally high. Among neurodegenerative …